×
For best experience we recommend to activate Javascript in your browser.
Paxillin antibody (pTyr31)
The Rabbit Polyclonal anti-Paxillin antibody has been validated for WB. It is suitable to detect Paxillin in samples from Human.
Quick Overview for Paxillin antibody (pTyr31) (ABIN2148485)
Target
See all Paxillin (PXN) Antibodies
Paxillin (PXN)
Reactivity
All reactivities for Paxillin antibodies
Human
Host
All hosts for Paxillin antibodies
Rabbit
Clonality
All clonalities for Paxillin antibodies
Polyclonal
Conjugate
All conjugates for Paxillin antibodies
This Paxillin antibody is un-conjugated
Application
All applications for Paxillin antibodies
Western Blotting (WB)
Product Details anti-Paxillin Antibody
(hide)
Binding Specificity
All epitopes for Paxillin antibodies
pTyr31
Purification
Paxillin antibody was purified by immunoaffinity chromatography.
Immunogen
Paxillin antibody was raised in Rabbit using the peptide sequence around phosphorylation site of Tyr31 (T-P-Y(p)-S-Y) derived from Human Paxillin as the immunogen.
Alternatives
(show)
Application Details
(hide)
Application Notes
WB: 1:500-1:1000
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
Lot specific
Buffer
In liquid form PBS buffer (no MG2+ or Ca2+), pH 7.4, 150 mm NaCl, 0.02 % sodium azide and 50 % glycerol.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handling Advice
Avoid repeated freeze/thaw cycles
Storage
-20 °C
Storage Comment
Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
Target Details for Paxillin
(hide)
Target
Paxillin (PXN)
Alternative Name
Paxillin
Pathways
MAPK Signaling , EGFR Signaling Pathway , Response to Growth Hormone Stimulus , Cell-Cell Junction Organization , Maintenance of Protein Location , CXCR4-mediated Signaling Events , Signaling Events mediated by VEGFR1 and VEGFR2 , Signaling of Hepatocyte Growth Factor Receptor , VEGF Signaling
Recently viewed
(hide)
Chat with us , powered by LiveChat